NFKB1 and rheumatoid arthritis: Sclareol not only ameliorated the histological destruction in synovial tissues but also suppressed the activation of the MAPKs and NF-κB translocation induced either by collagen or IL-1β, endowing sclareol with a new pivotal role in the combat of rheumatoid arthritis.